🇺🇸

US SEC Filing Intelligence

· daily

US SEC Filings Daily Market Digest — May 22, 2026

Today's filings reveal a market bifurcated between aggressive growth plays and defensive consolidation. The standout theme is the massive utility sector consolidation, with Dominion Energy's $2.24 billion termination-fee merger with NextEra Energy signaling a bet on surging electricity demand. However, this is juxtaposed against severe distress in the small-cap and micro-cap space, where companies like Transuite.Org (net loss ballooning to $37.2M from $0.4M), Allied Gaming (revenue down 12.2%, losses widening to $34.6M), and Trutankless (cash down 98% despite 347% revenue growth) are burning cash at alarming rates. On the positive side, Take-Two Interactive's 18.2% revenue growth and Vodafone's swing to an operating profit of €2.8B from a loss show that scale and recurring revenue models are winning. Insider activity is sparse but notable, with Stifel Financial's board facing an unusual proxy fight over equity compensation, while the failed Estée Lauder-Puig deal signals a cooling in luxury M&A. The SPAC market is showing signs of life with three new IPOs filing, but the continued extension payments by Cayson Acquisition Corp highlight the pressure to find deals. Overall, the data suggests a 'haves and have-nots' market where cash flow positive, large-cap names are consolidating power, while speculative, pre-revenue companies face existential liquidity crises.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 22, 2026

The 50 filings for the S&P 500 Consumer Discretionary stream reveal a sector bifurcated between aggressive growth plays and defensive deleveraging. Key themes include a wave of transformative M&A and capital raises (BuzzFeed, Functional Brands, Blue Owl Digital Infrastructure) aimed at pivoting business models, contrasted with a focus on debt reduction and asset sales (Armada Hoffler, Ashford Hospitality). Period-over-period data shows strong top-line growth at Take-Two (+18.2% YoY) and Reborn Coffee (+207.8% YoY), but also highlights persistent profitability challenges, with several companies still reporting net losses despite revenue gains. Insider activity is minimal in this batch, but significant board and management changes at BuzzFeed, Surf Air Mobility, and Powerfleet signal strategic shifts. Shareholder meetings reveal notable dissent on executive compensation at Marsh & McLennan (11.5% against) and Wayfair (24.6% against), while capital allocation trends show a mix of dividend increases (Vodafone, Alerus Financial) and aggressive share issuance (Faraday Future). The most critical development is the $2.85B data center acquisition by Blue Owl Digital Infrastructure, signaling massive institutional capital flowing into AI infrastructure, while BuzzFeed's $120M Byron Allen deal represents a high-risk pivot for a digital media firm.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 22, 2026

The 38 filings from the S&P 500 Healthcare stream reveal a sector bifurcated between established players executing capital market strategies and small/mid-cap biotechs facing acute liquidity and compliance crises. Key period-over-period trends are stark: pre-revenue biotechs like Lakewood-Amedex saw net losses widen 71% YoY with cash burning to just $11,709, while Scienture Holdings achieved a 449% YoY revenue surge to $56k, albeit from a negligible base. A dominant theme is the wave of Nasdaq delinquency notices, with three companies (RCI Hospitality, Anavex Life Sciences, Ensysce Biosciences) receiving delisting threats for delayed filings or equity shortfalls, signaling a potential shakeout in micro-cap healthcare. On the capital allocation front, Merck & Co. raised $6.0 billion in a seven-tranche debt offering for general corporate purposes, while News Corp reiterated its $1 billion buyback authorization, highlighting divergent capital strategies. Insider activity was limited to executive transitions, with Vishay Precision Group's CFO retirement and Newmark Group's new CSO appointment, providing no clear directional signal from management. The most critical development is the expansion of Assembly Biosciences' ABI-6250 into PBC/PSC, a high-potential catalyst with Phase 2 starts in Q4 2026 and Q1 2027, contrasting with the existential risks faced by cash-strapped entities. Overall, the portfolio-level pattern is one of capital concentration in larger firms and survival-mode dynamics in smaller names, demanding a selective, catalyst-driven approach.

11 high priority 27 medium 38 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 22, 2026

This batch of 9 proxy filings reveals a mixed picture for the 2026 annual meeting season, with several high-stakes votes on compensation, capital structure, and business combinations. A key theme is the tension between growth and profitability: Laird Superfood posted 15% revenue growth but saw gross margins contract 300 bps and net losses widen to $3.3M, while GameStop is seeking approval for a CEO performance award tied to market cap and EBITDA hurdles, signaling a focus on profitability. Insider activity is sparse, but the near-certain approval of Athena Technology's extension (Sponsor holds 99.7% of shares) creates a unique arbitrage opportunity with shares trading at a $2.71 discount to trust value. Capital allocation trends are divergent—Laird funded two acquisitions with $86.5M in cash from a preferred investment, while GameStop proposes increasing authorized shares, raising dilution concerns. Across the filings, governance proposals are largely uncontested, but the reverse stock splits at Kairos Pharma and Cambium Networks highlight distress signals in micro-cap names. The most critical developments are the potential redemption outflow at Athena Technology and the shareholder vote on GameStop's performance award, which could set a precedent for CEO compensation in the retail sector.

9 high priority 9 total filings
· daily

US IPO Pipeline SEC S-1 Filings — May 22, 2026

Today's IPO pipeline digest covers 7 S-1 filings, revealing a market bifurcated between high-risk, capital-intensive growth stories and traditional blank-check vehicles. The most critical development is the surge in SPAC activity, with two new $450M+ offerings (Cantor Equity Partners VII and Snow Rothschild Acquisition Corp.) signaling renewed sponsor confidence, though both carry extreme dilution risks for public shareholders. On the operational front, iQSTEL and Flux Power highlight a troubling pattern: both are going public with significant accumulated deficits and going-concern qualifications, relying on dilutive equity lines or debt restructurings for survival. Nuwellis stands out as the highest-risk filing, facing a proposed Nasdaq rule change that could force delisting, while Hyperliquid's unique structure (reverse recapitalization with HYPE token exposure) introduces novel crypto-accounting risks. Period-over-period trends are sparse in these initial filings, but the common thread is that 5 of 7 companies are emerging growth companies electing reduced disclosure, masking true financial health. The most actionable insight is the 60-month equity line at iQSTEL, which provides a $50M capital backstop but at a guaranteed 6% discount to market, creating a predictable dilution overhang that active traders can exploit.

7 high priority 7 total filings
· daily

Global High-Priority Regulatory Events — May 22, 2026

The 50 filings from May 22, 2026, reveal a market landscape dominated by corporate restructurings, regulatory actions, and significant capital allocation events. A key theme is the divergence between strong top-line growth and margin compression or cash flow concerns, as seen in Take-Two Interactive (revenue +18.2% YoY but still net loss-making) and Greenpanel Industries (revenue +15.5% YoY but net loss due to forex losses). The SPAC and M&A space is highly active, with the Dominion Energy-NextEra Energy merger ($2.24B termination fee) and the Galera-Obsidian merger representing high-stakes consolidation. Insider activity is mixed, with significant pledges at Paisalo Digital and Anand Rathi Wealth, while the lack of insider buying in distressed names like Transuite.Org and Allied Gaming signals caution. Capital allocation is a bright spot, with large buybacks from Wipro (₹15,000 Cr) and Garware Technical Fibres (₹110 Cr), and dividends from TTK Prestige and Ashok Leyland, indicating management confidence in select companies. However, regulatory risks are elevated, with AGI Greenpac appealing a SEBI order and Santosh Fine-Fab reporting multiple compliance lapses. The overall sentiment is cautious, with a focus on liquidity and execution risk, particularly in the SPAC and pre-revenue tech sectors.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 22, 2026

The 30 filings reveal a bifurcated market: high-growth companies like Trutankless (+347% YoY revenue) and Reborn Coffee (+208% YoY) show explosive top-line expansion but face severe cash burn and liquidity risks, while established firms like CorVel (+7% revenue, +16% net income) and Workday (+13.5% revenue) demonstrate steady growth with improving margins. A notable theme is the prevalence of SPACs and pre-revenue companies (Pyrophyte, Thunder Power, Two Hands) reporting widening losses and cash depletion, with 5 of 30 filings showing zero revenue. Insider activity is sparse but includes significant share repurchases at Williams-Sonoma ($287.8M) and Workday ($1.6B), signaling management confidence. Capital allocation trends favor buybacks over dividends, with 4 companies aggressively repurchasing shares. The office REIT sector (OPIRQ) remains distressed, with three consecutive quarterly losses and Chapter 11 restructuring. Overall, the data suggests investors should favor companies with positive operating cash flow and sustainable growth, while avoiding cash-burning entities with going-concern risks.

30 high priority 30 total filings
· daily

US SEC Trading Suspension Halt Orders — May 22, 2026

Over the past 24 hours, 16 companies disclosed Nasdaq non-compliance events, with 12 new filings and 4 previously covered. The dominant theme is filing delinquency: 10 of 16 companies received deficiency notices for late 10-K or 10-Q filings, reflecting systemic reporting failures. Additionally, 5 companies face minimum stockholders' equity shortfalls, and 2 have bid price deficiencies. The concentration of notices on May 19-21 suggests a batch review by Nasdaq. Insider trading data is absent across all filings, indicating no management conviction signals. Capital allocation data is minimal, with no dividends or buybacks reported. Forward-looking statements are limited to compliance plans and potential extensions, with deadlines clustering in June-July 2026. The sector is heavily weighted toward micro-cap biotech and tech firms, amplifying delisting risk. No positive period-over-period trends were identified; all metrics are deteriorating. The most critical development is the potential for multiple delistings by October 2026 if compliance is not regained.

16 high priority 16 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 22, 2026

The 50 filings reveal a surge in corporate distress signals, with 12 companies receiving Nasdaq deficiency notices for late filings or equity shortfalls, and several others engaging in dilutive financing or asset sales to shore up liquidity. Key themes include a wave of going-concern warnings, aggressive capital raises via convertible notes and ATM offerings, and strategic pivots into AI and digital infrastructure. Notable positive signals include Crescent Energy's credit facility expansion and Corpay's refinancing, which lower borrowing costs and extend maturities. However, the prevalence of insider selling, covenant breaches, and delayed filings underscores a fragile environment for small-cap and micro-cap issuers. Investors should focus on companies with strong period-over-period revenue growth and insider buying, while avoiding those with repeated compliance failures and negative sentiment.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — May 22, 2026

The 47 filings from May 22, 2026, reveal a heavy concentration on annual meeting outcomes and director/officer transitions, with a notable undercurrent of shareholder dissent on equity plan amendments and governance proposals. While most director elections passed with strong support, several companies (Wayfair, Travelers, Investar, Babcock & Wilcox) saw significant opposition (15-26%) to equity plan increases, signaling investor fatigue with dilution. A key trend is the formalization of CFO/executive departures with structured transition agreements (Nerdy, VPG, Neuronetics), often including consulting periods and severance, suggesting companies are prioritizing orderly successions. Insider activity was limited, but the appointment of Jeff Miller (Halliburton CEO) to Noble Corp's board is a high-conviction signal for the offshore drilling sector. Capital allocation trends were mixed: SS&C announced a $1.5B buyback and dividend, while First Busey and LyondellBasell expanded repurchase programs, contrasting with the general focus on equity plan amendments. The most critical development is the high level of 'against' votes on compensation and equity plans, which could pressure boards to reform pay practices. Overall, the data suggests a cautious but active governance environment, with investors closely scrutinizing management incentives and capital use.

47 high priority 47 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 22, 2026

The 46 filings from May 22, 2026, reveal a busy annual meeting season with significant board and executive changes across sectors. A key theme is notable shareholder dissent on equity plan amendments and director elections, with several companies (Investar, Travelers, Babcock & Wilcox) seeing 19-27% opposition on share issuances, signaling potential governance concerns. Insider activity is mixed: positive signals from Nine Energy's permanent CFO appointment and Noble Corp's addition of Halliburton's CEO, offset by three simultaneous director resignations at Tempest Therapeutics and a CFO departure at Nerdy. Capital allocation trends show strong shareholder returns, with SS&C Technologies announcing a $1.5B buyback and LyondellBasell a 10% share repurchase authorization. Sector-wise, financials and energy companies are actively managing board composition, while tech firms face higher scrutiny on compensation plans. The data suggests investors should focus on companies with high opposition rates on governance proposals as potential activism targets, while monitoring insider movements for leadership stability signals.

46 high priority 46 total filings
· daily

US Merger & Acquisition SEC Filings — May 22, 2026

The May 22, 2026, SEC filings reveal a market dominated by SPAC activity, with four IPOs (Iron Dome, Berto, Patriot, Peace) raising a combined $685.1 million and two SPACs (Cayson, Range) seeking shareholder approval to extend their business combination deadlines, indicating a bifurcated market where well-capitalized new SPACs launch while existing ones struggle to find targets. The real estate sector shows active portfolio repositioning: Ashford Hospitality Trust sold a hotel for $37.2M to reduce debt, Generation Income Properties divested a single-tenant retail property for $2.96M, and Armada Hoffler Properties executed a massive $485M multifamily sale to accelerate deleveraging toward a 5.5x-6.5x net debt/EBITDA target. A notable period-over-period trend is the significant accumulated deficits among newly public SPACs—Iron Dome ($8.5M), Patriot ($5.4M)—highlighting the structural costs of going public before operations begin. Insider activity is limited but notable: the Cayson Acquisition insiders continue to fund monthly $125K trust deposits to extend the deal timeline, signaling commitment to finding a target. Forward-looking data points to a catalyst-rich calendar with Range Capital's June 18 shareholder meeting and multiple SPAC unit separations on May 28. The most critical development is Armada Hoffler's $485M portfolio sale, which provides a clear deleveraging catalyst and signals strong institutional demand for multifamily assets.

12 high priority 12 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 22, 2026

This batch of 50 SEC filings, dominated by overnight submissions ahead of the US market open, reveals a clear bifurcation between established operators delivering steady results (Take-Two, Vodafone, Dominion/NextEra merger) and a cohort of micro-cap and distressed companies facing severe liquidity and going-concern risks (Transuite, Trutankless, Allied Gaming). Period-over-period trends highlight a mixed picture: revenue growth is evident in selective names like Trutankless (+347% YoY) and Take-Two (+18.2% YoY), while margin compression and widening losses plague others (Allied Gaming G&A surged 132.7% YoY, Booz Allen revenue fell 6% YoY). The most critical development is the Dominion Energy-NextEra merger, a $2.24B termination-fee deal facing complex regulatory hurdles, and the terminated Estée Lauder/Puig talks, which reset sector M&A expectations. Notable insider and capital allocation activity is sparse, with the primary signals coming from IPO filings (Hyperliquid, Medline, Xanadu Quantum) and SPAC extensions (Tribeca, AmperCap, Cayson), indicating continued appetite for new issuance despite market uncertainty. A significant risk cluster emerges around Nasdaq non-compliance and filing delays (Allied Gaming, Comscore director's former employer bankruptcy), while the handful of positive catalysts—Starfighters Space $17.5M investment, GameStop's performance award tied to EBITDA/market cap—offer selective alpha opportunities. Overall, the digest points to a 'quality vs. junk' divergence where investors should favor companies with strong cash flows (Booz Allen $1.04B OCF, Take-Two positive FCF) and avoid deeply distressed micro-caps with minimal cash and negative working capital.

25 high priority 25 medium 50 total filings
· daily

New Federal Contractors — May 21, 2026

This digest covers five civilian government contracts totaling $755.9 million, all awarded by non-Defense agencies, with zero defense-related exposure. The dominant theme is Health and Human Services (HHS) spending, accounting for four of five contracts and $685.3 million (91%) of total obligation, led by a $432.5 million Leidos Biomedical Research NIH facility operations award. The highest-conviction signal is Peraton Inc.'s $95.1 million CMS Fraud Prevention System 2 win, reflecting durable political support for healthcare fraud IT. A key risk is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest signals stable, multi-year civilian IT and R&D spending, but with low margin upside due to cost-plus and fixed-price structures, and no defense sector catalysts.

5 total filings
· daily

Significant Contract Modifications ($10M+) — May 21, 2026

This digest covers $755.9 million in total obligations across five civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for four of five contracts and $685.3 million (91% of total value), led by a $432.5 million Leidos Biomedical Research GOCO facility operations award from NIH. The highest-conviction signal is Leidos' stable, multi-year cost-plus revenue stream, though only $1.15 million has been outlaid to date, signaling early-stage execution risk. A key watch item is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, which creates a potential revenue cliff for that small business. General Dynamics Information Technology's $70.6 million initial obligation on a $1.25 billion ceiling GSA IT contract provides long-term visibility but faces full-and-open competition pressure. No bearish signals were identified, but neutral ratings on three contracts reflect pricing risk, expiration cliffs, or minimal actual revenue recognition.

5 total filings
· daily

Contract Deobligations Alert — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for $685.3 million (90.7%) of the total, led by a $432.5 million NIH GOCO facility operations contract to Leidos Biomedical Research and a $95.1 million CMS fraud prevention system award to Peraton. The highest-conviction signal is Leidos' stable, multi-year NIH revenue stream, though only $1.15 million has been outlayed to date, indicating early-stage execution risk. A key watch item is SOFTRAMS LLC's $80.7 million CMS IT contract expiring in August 2024, creating a potential revenue cliff for the small business. Overall, the digest reflects steady civilian IT and R&D spending but lacks the growth catalysts typical of defense contracts.

5 total filings
· daily

Contract Option Exercises — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contract actions, with zero defense-related awards, underscoring a concentrated non-DOD procurement theme. The dominant agency is the Department of Health and Human Services (HHS), accounting for 90.7% of total value via NIH, CMS, and BARDA awards. The highest-conviction signal is Leidos Biomedical Research's $432.5 million GOCO facility contract with NIH, providing a stable, multi-year revenue stream albeit with cost-plus margin constraints. A key risk is the upcoming August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest points to steady civilian IT and life sciences R&D spending, but lacks the growth catalysts or margin upside typical of defense contracts.

5 total filings
· daily

Federal IT & Cybersecurity Contracts — May 21, 2026

This digest covers $246.4 million in total obligations across three civilian federal IT contracts, with zero defense-related awards. The dominant theme is healthcare IT modernization and fraud prevention at the Centers for Medicare and Medicaid Services (CMS), which accounts for $175.7 million (71%) of the total. The highest-conviction signal is Peraton Inc.'s $95.1 million Fraud Prevention System 2 award, a time-and-materials contract that provides stable, recurring revenue through 2026-2027 in a politically supported area. A key risk is SOFTRAMS LLC's $80.7 million contract expiring in August 2024, creating a potential revenue cliff if not renewed or recompeted.

3 total filings
· daily

All HHS Contracts — May 21, 2026

This digest covers $685.3 million in HHS contract obligations from May 21, 2026, with zero defense exposure, underscoring a pure civilian healthcare IT and life sciences R&D theme. The dominant signal is a $432.5 million Leidos Biomedical Research GOCO facility contract with NIH, representing 63% of total value and providing stable, multi-year cost-plus revenue. A $95.1 million Peraton fraud prevention contract with CMS adds a high-conviction, politically supported IT growth play. Key risks include a $80.7 million SOFTRAMS HUBZone contract expiring August 2024 (revenue cliff) and a $77.1 million Chimerix BARDA contract that was largely unfunded, highlighting execution risk. The highest-conviction signal is Peraton's CMS Fraud Prevention System 2 award, given CMS's sustained focus on fraud reduction and the time-and-materials pricing flexibility.

4 total filings